Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Laekna Raises $61 Million for its 14-Drug Cancer/Liver Disease Portfolio

publication date: May 18, 2022

Shanghai Laekna Therapeutics raised $61 million in a Series D financing for its next-gen cancer and liver disease medicines. Founded in 2017, the company has built a portfolio that consists of 14 novel drug candidates, including six clinical programs, three of which are multi-regional clinical trials (including one pivotal trial). Laekna has acquired at least four drug candidates from Novartis: an androgen inhibitor in 2017; two Akt inhibitors in 2018; and an anti-PD-1 antibody in 2020.  The company’s latest funding was led by CS Capital and joined by Worldstar and Infinity Capital. More details...,

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here